The benz [a]anthraquinones are a class of compounds that have attracted a great deal of attention owing to their interesting biological properties.
grown on a medium containing dextrose (0.1%), soluble starch 2.4%, soy peptone 0.3%, yeast extract 0.5%, Tryptone 0.5%, soya flour 0.5%, NaCl 0.54%, KCl 0.02%, MgCl 2 0.24%, Na 2 SO 4 0.75% and CaCO 3 0.4% in tap water, and cultured at 28 1C on an orbital shaker for 72 h. For production, 12.5 ml of the seed medium was transferred into 2000-ml Erlenmeyer flasks containing 250 ml of fermentation medium, comprising yeast extract 0.5%, soy peptone 0.1%, dextrose 0.5%, soya flour 0.3%, Glucidex 2.0%, NaCl 0.53%, KCl 0.02%, MgCl 2 Á6H 2 O 0.24%, Na 2 SO 4 0.75%, MnSO 4 Á4H 2 O 0.00076%, CoCl 2 Á6H 2 O 0.0001%, K 2 HPO 4 0.05% and CaCO 3 0.4%. The culture was grown at 28 1C using an orbital shaker (5-cm eccentricity, 220 r.p.m.) for 5 days.
The bioassay-guided isolation of 1 from the fermentation broth is depicted in Figure 2 and summarized below.
The fermentation broth (6 l) was subjected to centrifugation, and the clarified broth was extracted with ethyl acetate 1 : 1 (v/v). The extract was concentrated to give a broth extract (382 mg). It was subjected to reversed-phase vacuum chromatography by a filter funnel on Polygoprep 100-50 mm C18, using a H 2 O-MeOH-CH 2 Cl 2 mixture as the eluting solvent. The cytotoxic activity was detected in fractions eluted with H 2 O : MeOH 3 : 1 (35 mg), 1 : 1 (100 mg) and 1 : 3 (50 mg). As these three fractions displayed similar HPLC profiles, they were combined and evaporated under reduced pressure, resulting in a crude extract (185 mg). This extract was then chromatographed on a reversed-phase (C-18) column eluted in a stepwise gradient with increasing ratios of MeOH in water, followed by CH 2 Cl 2 in MeOH. Three out of the fourteen fractions eluted with H 2 O-MeOH mixtures showed antitumor activity and similar HPLC profiles. Further purification of two of these active fractions by preparative HPLC was carried out at room temperature using a C-18 Atlantis column (19Â150 mm, 5 mm, Waters). A gradient of CH 3 CN/H 2 O (15-60% in 20 min) was employed as a mobile phase, with a flow rate of 13.65 ml min -1 with UV detection at 215 nm. Under these conditions, a total amount of 5 mg of pure 1 was isolated, along with traces of 2. 1 The structure of 1 was established as shown in Figure 1 on the basis of analysis of the physico-chemical properties (Table 1 ) and NMR data (Table 2) , and by comparison with data reported for the related angucyclinone 2. 1 The physico-chemical properties of 1 are summarized in Table 1 . Compound 1 was obtained as a reddish powder. Its molecular formula was determined as C 21 H 18 O 6 , on the basis of high resolution electrospray ionization mass spectrum (HR-ESI-MS) and the NMR data (Table 2) , indicating 13 degrees of unsaturation.
The ESI-MS experiments showed ions at m/z 367 (M+H) and 389 (M+Na), which confirmed the molecular mass. The UV spectrum of 1 in MeOH exhibited absorption maxima at 203 and 408 nm, indicating the presence of a substituted anthraquinone moiety. The IR indicated the presence of hydroxyl groups (3353 cm À1 ). In addition, a strong absorption peak at 1639 cm À1 and the absence of a peak near 1670 cm À1 indicated that both carbonyls were involved in hydrogen bonding to neighbouring hydroxyls. 7,8 As described for 2, the absence of an IR band at around 1700-1725 cm À1 , assigned to the C-1 carbonyl in related antibiotics, suggested the presence of a hydroxyl group, hydrogen bonded to the C-12 quinone carbonyl, attached to the C-1 position (see Table 1 ).
The 1 H NMR spectrum of 1 exhibited a signal at d 4.00 for an aromatic methoxy group (Table 2) . Moreover, a pair of coupled signals at d 4.59 (H-5) and 5.12 (H-6) revealed the presence of a 5,6-diol moiety in 1. Two more signals were observed as doublets with a small coupling constant at d 6.76 (H-2) and 6.86 (H-4), each integrating for one proton, representing meta-coupled aromatic protons. In addition, an aromatic ABX system with a pattern very similar to that observed for 2 1 was present in the 1 H NMR spectrum of 1. However, no signals for a benzylic hydroxymethyl group were observed compared with 2. Instead, coupled signals at d 1.26 (H 3 -14) and 2.64 (H 2 -13) clearly indicated the presence of an ethyl group attached to the C-3 position. Assignment of the rest of the benz[a]anthraquinone signals was confirmed by 2-D NMR experiments. In the 1 H-1 H COSY, correlations of H-10 with H-9 and H-11, H-5 with H-6 and H-13 with H-14 revealed the linkages in these substructures. A correlation between the H-5 and H-6 protons in the COSY, together with the observed coupling constant for both protons (3 Hz), suggested the same trans stereochemistry as that of PD 116740, the X-ray diffraction analysis of which has been described in the literature. 1 The rest of the correlations observed in the ROESY (that is, H-4 with H-5 and H-13; H-2 with H-13; H-9 with H-15) were consistent with the proposed structure (Figure 3) . The relationship between these fragments was established through the heteronuclear multibond correlation (HMBC) NMR spectrum. The H 3 -15 methoxy group at d 4.00 was coupled to the aromatic carbon C-8, indicating its position. Moreover, long-range couplings observed between H-13 with C-2 and C-4 showed the position of the ethyl group (Figure 3) . Long-range couplings observed between H-4 with C-2, C-12b and C-5, and between H-6 with C-4a, C-12a and the carbonyl group C-7 indicated two substructures fused through C-6-C-6a and C-12a-C-12b, which was further supported by cross peaks between H-5 with C-6a and between H-2 with C-12b in HMBC as complementary evidence (Figure 3) . On the other hand, PM070747, a new cytotoxic angucyclinone M Pérez et al C-7a was assigned by its correlation with H-11, and the C-11a position was revealed by a cross peak between H-10 and C-11a in HMBC (Figure 3) . The antitumor activity of 1 was evaluated against a panel of three tumor cell lines: human breast adenocarcinoma MDA-MB-231 cells, human colorectal adenocarcinoma HT-29 cells and human lung carcinoma A-549 cells (concentration of 50% inhibition on cell growth (GI 50 ) 0.71, 1.42 and 3.28 mM, respectively), according to the procedure described in the literature. 9 Cell survival was estimated using the National Cancer Institute algorithm. 10 Three dose-response parameters were calculated for 1 (Table 3) . , 2959, 1730, 1639, 1376, 1340, 860, 839, 801, 738, 663 (a) D 25 (c¼0.32, MeOH) +220 
